Follicular mucinosis associated with early stage cutaneous T-cell lymphoma: successful treatment with interferon alpha-2b and acitretin

J Dermatolog Treat. 2001 Jun;12(2):117-21. doi: 10.1080/095466301317085435.

Abstract

Background: Follicular mucinosis (FM) is a rare dermatosis characterized by mucin deposits in the pilosebaceous units. It is divided into a primary-benign type and a secondary type associated mostly with lymphomas. No standard effective therapy is available for the primary FM while in the secondary form treatment is aimed against the underlying disease.

Methods: We report a case of secondary FM in which a cutaneous T-cell lymphoma was detected 6 years after the initial eruption.

Results: Complete remission was achieved with combination therapy of interferon alpha-2b at a dose of 6 million U subcutaneously three times a week, and acitretin 35 mg/day, for 6 months.

Conclusion: Regular clinical and histopathological evaluation is suggested for all patients with FM. For cases associated with cutaneous T-cell lymphoma the combination of interferon alpha and acitretin seems to be a good therapeutical approach.

Publication types

  • Case Reports

MeSH terms

  • Acitretin / administration & dosage*
  • Adult
  • Drug Therapy, Combination
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Keratolytic Agents / administration & dosage*
  • Lymphoma, T-Cell, Cutaneous / complications*
  • Mucinosis, Follicular / complications
  • Mucinosis, Follicular / drug therapy*
  • Paraneoplastic Syndromes / drug therapy*
  • Recombinant Proteins

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Keratolytic Agents
  • Recombinant Proteins
  • Acitretin